Mark A Ritter

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. pmc Hypofractionation for prostate cancer
    Mark Ritter
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Cancer J 15:1-6. 2009
  2. pmc Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer
    Mark Ritter
    Department of Human Oncology and Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Semin Radiat Oncol 18:249-56. 2008
  3. pmc Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer
    Jarrod B Adkison
    Department of Human Oncology, University of Wisconsin Carbone Cancer Center, School of Medicine and Public Health, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 82:184-90. 2012
  4. pmc Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI 53792, USA
    Cancer 117:2629-36. 2011
  5. ncbi request reprint Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy
    Theodore S Hong
    Department of Human Oncology, University of Wisconsin Medical School, Madison, WI 53792, USA
    Acta Oncol 45:717-27. 2006
  6. ncbi request reprint Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy
    Gordon W Wong
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 70:449-55. 2008
  7. pmc A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments
    Leah K Schubert
    Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    Int J Radiat Oncol Biol Phys 73:1260-9. 2009
  8. ncbi request reprint Integral radiation dose to normal structures with conformal external beam radiation
    Hidefumi Aoyama
    Department of Human Oncology, University of Wisconsin, Madison, WI, USA
    Int J Radiat Oncol Biol Phys 64:962-7. 2006
  9. ncbi request reprint Megavoltage computed tomography: an emerging tool for image-guided radiotherapy
    Theodore S Hong
    Department of Human Oncology, University of Wisconsin Medical School, Madison, WI, USA
    Am J Clin Oncol 30:617-23. 2007
  10. ncbi request reprint The alpha/beta ratio for prostate cancer: what is it, really?
    Søren M Bentzen
    Department of Human Oncology, University of Wisconsin Medical School, WI 53792, USA
    Radiother Oncol 76:1-3. 2005

Research Grants

Collaborators

Detail Information

Publications33

  1. pmc Hypofractionation for prostate cancer
    Mark Ritter
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Cancer J 15:1-6. 2009
    ..With hypofractionation's significant potential for therapeutic gain, cost savings, and improved patient convenience, the future management of localized prostate cancer could be profoundly altered in the process...
  2. pmc Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer
    Mark Ritter
    Department of Human Oncology and Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Semin Radiat Oncol 18:249-56. 2008
    ..Clinical validation permitting, the adaptation of hypofractionation as a standard of care could profoundly influence future management of localized prostate cancer...
  3. pmc Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer
    Jarrod B Adkison
    Department of Human Oncology, University of Wisconsin Carbone Cancer Center, School of Medicine and Public Health, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 82:184-90. 2012
    ..In a prospective trial, we tested whether image-guided intensity-modulated radiation therapy (IMRT) can safely deliver escalated nodal doses while treating the prostate with hypofractionated radiotherapy in 5½ weeks...
  4. pmc Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence
    Tim J Kruser
    Department of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI 53792, USA
    Cancer 117:2629-36. 2011
    ..5 to 8 weeks of treatment. The authors report on the safety and efficacy of an expedited radiotherapy course for salvage prostate radiotherapy...
  5. ncbi request reprint Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy
    Theodore S Hong
    Department of Human Oncology, University of Wisconsin Medical School, Madison, WI 53792, USA
    Acta Oncol 45:717-27. 2006
    ..A phase II trial to more thoroughly examine this treatment approach is currently underway...
  6. ncbi request reprint Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy
    Gordon W Wong
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 70:449-55. 2008
    ..To evaluate whether hypofractionation is well tolerated and to preliminarily assess biochemical control of this regimen in a postprostatectomy, salvage setting...
  7. pmc A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments
    Leah K Schubert
    Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    Int J Radiat Oncol Biol Phys 73:1260-9. 2009
    ..To assess patient setup corrections based on daily megavoltage CT (MVCT) imaging for four anatomic treatment sites treated on tomotherapy...
  8. ncbi request reprint Integral radiation dose to normal structures with conformal external beam radiation
    Hidefumi Aoyama
    Department of Human Oncology, University of Wisconsin, Madison, WI, USA
    Int J Radiat Oncol Biol Phys 64:962-7. 2006
    ..This study was designed to evaluate the integral dose (ID) received by normal tissue from intensity-modulated radiotherapy (IMRT) for prostate cancer...
  9. ncbi request reprint Megavoltage computed tomography: an emerging tool for image-guided radiotherapy
    Theodore S Hong
    Department of Human Oncology, University of Wisconsin Medical School, Madison, WI, USA
    Am J Clin Oncol 30:617-23. 2007
    ..In this study, we assessed the image-quality, absorbed radiation doses, and clinical practicality of MVCT from our helical tomotherapy prototype unit...
  10. ncbi request reprint The alpha/beta ratio for prostate cancer: what is it, really?
    Søren M Bentzen
    Department of Human Oncology, University of Wisconsin Medical School, WI 53792, USA
    Radiother Oncol 76:1-3. 2005
    ..Taken together, the outcomes of these two studies still favor a high fractionation sensitivity of prostate cancer...
  11. ncbi request reprint Helical tomotherapy: image guidance and adaptive dose guidance
    Wolfgang A Tome
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Front Radiat Ther Oncol 40:162-78. 2007
    ....
  12. ncbi request reprint Helical tomotherapy: an innovative technology and approach to radiation therapy
    James S Welsh
    Department of Human Oncology, University of Wisconsin, School of Medicine, 600 Highland Avenue, Madison, WI 53792, USA
    Technol Cancer Res Treat 1:311-6. 2002
    ..Based on radiobiological principles that exploit the physical advantages of helical tomotherapy, several dosimetric and clinical investigations are underway...
  13. ncbi request reprint Optimal stochastic correction strategies for rigid-body target motion
    Harry Keller
    Department of Medical Physics, University of Wisconsin, Madison, WI 53706, USA
    Int J Radiat Oncol Biol Phys 55:261-70. 2003
    ..To derive optimal correction strategies for setup errors, including the uncertainty in their measurement, and to analyze their impact on treatment margins...
  14. ncbi request reprint The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer
    Mark A Ritter
    Department of Human Oncology, University of Wisconsin, 600 Highland Avenue, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 53:574-80. 2002
    ....
  15. ncbi request reprint Effect of medical castration on CYP3A4 enzyme activity using the erythromycin breath test
    Paul R Hutson
    School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705, USA
    Cancer Chemother Pharmacol 62:373-7. 2008
    ..Medical or surgical castration is a standard treatment of progressive prostate carcinoma, but the effect of the subsequent fall of testosterone concentrations upon drug metabolism has not been reported...
  16. ncbi request reprint Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy
    James S Welsh
    Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA
    Technol Cancer Res Treat 5:465-79. 2006
    ....
  17. ncbi request reprint Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer
    Rakesh R Patel
    Department of Radiation Oncology, University of Wisconsin, 600 Highland Avenue K4 B100, Madison, WI 53792, USA
    Radiother Oncol 67:285-94. 2003
    ....
  18. ncbi request reprint What hypofractionated protocols should be tested for prostate cancer?
    Jack F Fowler
    Department of Human Oncology, University of Wisconsin Madison, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 56:1093-104. 2003
    ..We analyze here possible high-gain/low-risk hypofractionated protocols for prostate cancer to test this suggestion...
  19. doi request reprint Analysis of urological procedures in men who died from prostate cancer using a population-based approach
    Kara Babaian
    Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    BJU Int 111:E65-70. 2013
    ..Furthermore, this study incorporates both hospital- and office-based procedures. This approach has not been previously undertaken...
  20. ncbi request reprint Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option
    Gregory W Allen
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA
    Cancer 110:1405-16. 2007
    ..It appears that salvage brachytherapy, when combined with careful patient selection, is at least as effective as other salvage options with comparable or potentially fewer treatment-related side effects...
  21. ncbi request reprint Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations
    Paul M Harari
    Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA
    Curr Probl Cancer 28:7-40. 2004
  22. ncbi request reprint Prognostic and predictive markers in radiation therapy: focus on prostate cancer
    Mark A Ritter
    Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA
    Cancer Treat Res 139:97-114. 2008
  23. ncbi request reprint Image guidance for precise conformal radiotherapy
    Thomas Rockwell Mackie
    Department of Human Oncology, University of Wisconsin, Madison, WI, USA
    Int J Radiat Oncol Biol Phys 56:89-105. 2003
    ..To review the state of the art in image-guided precision conformal radiotherapy and to describe how helical tomotherapy compares with the image-guided practices being developed for conventional radiotherapy...
  24. ncbi request reprint Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors
    Paul M Harari
    Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center and School of Medicine, Madison, WI 53792, USA
    Semin Radiat Oncol 13:3-12. 2003
    ..However, we lack randomized trials that directly compare operative versus nonoperative treatment approaches and thus have consciously neglected review of the surgical series for purposes of this article...
  25. ncbi request reprint Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer
    Vinai Gondi
    Department of Human Oncology, University of Wisconsin, Madison, WI, USA
    Int J Radiat Oncol Biol Phys 67:187-95. 2007
    ..The aim of this study was to investigate the impact of a hybrid fluorodeoxyglucose positron-emission tomography/computed tomography (FDG-PET/CT) scanner in radiotherapy planning for esophageal and non-small-cell lung cancer (NSCLC)...
  26. ncbi request reprint 3D-ultrasound guided radiation therapy in the post-prostatectomy setting
    Prakash Chinnaiyan
    Department of Human Oncology K4 B100, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792, USA
    Technol Cancer Res Treat 2:455-8. 2003
    ....
  27. ncbi request reprint How low is the alpha/beta ratio for prostate cancer? In regard to Wang et al., IJROBP 2003;55:194-203
    Jack F Fowler
    Int J Radiat Oncol Biol Phys 57:593-5; author reply 595-6. 2003
  28. ncbi request reprint The prospects for new treatments for prostate cancer
    Jack F Fowler
    Int J Radiat Oncol Biol Phys 52:3-5. 2002
  29. ncbi request reprint Prostate cancer--which treatment to choose?
    Jarrod B Adkison
    Arch Intern Med 168:1352; author reply 1353. 2008
  30. ncbi request reprint Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers
    Ramesh K Ramanathan
    Division of Hematology Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Cancer Chemother Pharmacol 57:465-74. 2006
    ..The pharmacokinetics of MGd were also evaluated...
  31. ncbi request reprint Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus
    Desiree Hao
    Tom Baker Cancer Centre, Alberta Cancer Board and the University of Calgary, Alberta, Canada
    Semin Radiat Oncol 16:10-9. 2006
    ..For each tumor type, we will review the state of the evidence and comment on the current state of practice and on future directions for clinical research in combined modality CT/RT...
  32. pmc COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial
    Li Yan Khor
    Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Lancet Oncol 8:912-20. 2007
    ..We aimed to study COX-2 overexpression and outcome in a well-defined cohort of men who received treatment with short-term androgen deprivation (STAD) plus radiotherapy or long-term androgen deprivation (LTAD) plus radiotherapy...
  33. pmc Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02
    Li Yan Khor
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Clin Cancer Res 13:3585-90. 2007
    ..A follow-up investigation was carried out here in more contemporary high-risk men treated on Radiation Therapy Oncology Group 92-02 with STAD+RT or long-term AD+RT (LTAD+RT)...

Research Grants7

  1. Biomarkers of Prostate Cancer Radiation Outcome
    Mark Ritter; Fiscal Year: 2007
    ..abstract_text> ..
  2. Hypofractionated IMRT for Localized Prostate Cancer
    Mark Ritter; Fiscal Year: 2007
    ..abstract_text> ..